OK Biotech Co (TPE:4155) Shares Outstanding (EOP): 141 Mil (As of Dec. 2025)


TPE:4155 OK Biotech Co Ltd TPE:4155
61 GF Score
Price NT$15.50
GF Value NT$27.26
Valuation Possible Value Trap
! 7 Warning Signs
View Full Analysis

What is OK Biotech Co Shares Outstanding (EOP)?

OK Biotech Co TPE:4155 +1.31% 61 Shares Outstanding (EOP) is 141 Mil as of Dec. 2025. GuruFocus rates TPE:4155 with a GF Score™ of 61/100 and a GF Value™ of NT$27.26 (Possible Value Trap). The stock has 7 warning signs investors should review.

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. OK Biotech Co's shares outstanding for the quarter that ended in Dec. 2025 was 141 Mil.

OK Biotech Co's quarterly shares outstanding declined from Sep. 2025 (145 Mil) to Dec. 2025 (141 Mil). It means OK Biotech Co bought back shares from Sep. 2025 to Dec. 2025 .

OK Biotech Co's annual shares outstanding declined from Dec. 2024 (147 Mil) to Dec. 2025 (141 Mil). It means OK Biotech Co bought back shares from Dec. 2024 to Dec. 2025 .


OK Biotech Co  (TPE:4155) Shares Outstanding (EOP) Explanation

A company may buy back shares or issue shares in any fiscal period. If a company buys back shares, we should observe that the total number of shares decline. If the company issues new shares, the number of shares outstanding increases.

Usually the presence of treasury shares and a history of buyback are good indicators that company has competitive advantage. But studies have shown that companies usually buy back at wrong time. Buying back shares below its intrinsic value increases value for remaining shareholders. Buying back overvalued shares destroys value for existing shareholders.


Be Aware

Warren Buffett looks for consistency and upward long term trend. Because of share repurchase it is possible for net earnings trend to differ from EPS trend. He preferred net income over EPS. The companies with durable competitive advantage companies report higher % net earnings to total revenues.

Important: If a company is showing net earnings history greater than 20% on total revenues, it is probably benefiting from a long term competitive advantage.

If net earnings is less than 10%, likely to be in a highly competitive business.


OK Biotech Co Shares Outstanding (EOP) Related Terms


OK Biotech Co Shares Outstanding (EOP) Historical Data

* Premium members only.

The historical data trend for OK Biotech Co's Shares Outstanding (EOP) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

OK Biotech Co Shares Outstanding (EOP) Chart

OK Biotech Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Shares Outstanding (EOP)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 105.61 112.21 145.77 147.06 141.12

OK Biotech Co Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Shares Outstanding (EOP) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 147.06 143.12 142.12 145.32 141.12

TPE:4155 vs ABT, SYK, MDT: Shares Outstanding (EOP) Comparison

For the Medical Devices subindustry, OK Biotech Co's Shares Outstanding (EOP), along with its competitors' market caps and Shares Outstanding (EOP) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


OK Biotech Co Shares Outstanding (EOP) vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, OK Biotech Co's Shares Outstanding (EOP) distribution charts can be found below:

* The bar in red indicates where OK Biotech Co's Shares Outstanding (EOP) falls into.


TPE:4155
61GF Score
OK Biotech Co Ltd TPE:4155
Shares Outstanding (EOP) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

OK Biotech Co Shares Outstanding (EOP) Calculation

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. They have voting rights and represent ownership in the corporation by the person that holds the shares. They should be distinguished from treasury shares, which are shares held by the corporation itself, having no exercisable rights.

Shares outstanding can be calculated as either basic or fully diluted. The fully diluted shares outstanding count includes diluting securities, such as options, warrants or convertibles.

Please note: GuruFocus named Shares Outstanding (EOP) is the shares for that end of period. It is usually used to calculate balance sheet related items, such as Book Value per Share, etc. While Shares Outstanding (Diluted Average) and Shares Outstanding (Basic Average) are the weighted average shares over a period of time (a year, a quarter, or so). They are usually used to calculate income statement or cashflow statement related items, such as Earnings per Share (Diluted), etc.

What does a Shares Outstanding (EOP) of 141 Mil mean?
OK Biotech Co (TPE:4155) has a Shares Outstanding (EOP) of 141 Mil as of Dec. 2025. The total shares a company has outstanding, at period-end. View historical data on OK Biotech Co and its competitors.
Is OK Biotech Co's Shares Outstanding (EOP) too high?
OK Biotech Co's current Shares Outstanding (EOP) is 141 Mil. Overall, OK Biotech Co has a GF Score™ of 61/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does OK Biotech Co's Shares Outstanding (EOP) compare to ABT and SYK?
OK Biotech Co's Shares Outstanding (EOP) of 141 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shares Outstanding (EOP) for a Medical Devices & Instruments company?
A good Shares Outstanding (EOP) depends on the Medical Devices & Instruments industry context. However, Shares Outstanding (EOP) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shares Outstanding (EOP) mean?
A high Shares Outstanding (EOP) can signal that a stock is expensive relative to its fundamentals. The total shares a company has outstanding, at period-end. View historical data on OK Biotech Co and its competitors. OK Biotech Co's current Shares Outstanding (EOP) is 141 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is OK Biotech Co stock overvalued right now?
Based on GuruFocus' analysis, OK Biotech Co (TPE:4155) is currently considered Possible Value Trap. The stock's GF Value™ is NT$27.26, compared to a current price of NT$15.50 — trading 43.1% below its estimated fair value. The current Shares Outstanding (EOP) is 141 Mil. OK Biotech Co's overall GF Score™ is 61/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shares Outstanding (EOP) calculated?
Shares Outstanding (EOP) is calculated from a company's financial statements. For OK Biotech Co (TPE:4155), the current Shares Outstanding (EOP) is 141 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is OK Biotech Co (TPE:4155) Overvalued in 2026?

Based on GuruFocus' analysis, OK Biotech Co stock appears to be undervalued. The current stock price of NT$15.50 is trading 43.1% below its estimated GF Value™ of NT$27.26. GuruFocus considers OK Biotech Co to be Possible Value Trap.

Key valuation signals for TPE:4155:

  • Shares Outstanding (EOP): 141 Mil
  • GF Value™: NT$27.26 vs. price of NT$15.50 (43.1% below fair value)
  • GF Score™: 61/100 with 7 warning signs

No single metric tells the full story. See the TPE:4155 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


OK Biotech Co Business Description

Address Gongdao 5th Road, Section 2, No. 91, Hsinchu, TWN, 30070
OK Biotech Co Ltd is mainly engaged in the manufacturing, wholesale, and retail of electronic materials and medical equipment. Its product portfolio comprises blood glucose monitoring systems, OTC hearing aids, multi-frequency therapy devices, and others. Geographically, the company generates the majority of its revenue from America, and the rest from Asia (excluding Taiwan), Africa, Europe, and Taiwan.
61GF Score

Get the complete analysis for TPE:4155

Shares Outstanding (EOP) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$15.50
Price
NT$27.26
GF Value